Tanaka Capital Management Inc Lowers stake in Celgene Corporation (CELG)

Celgene Corporation (CELG) : Tanaka Capital Management Inc reduced its stake in Celgene Corporation by 32.64% during the most recent quarter end. The investment management company now holds a total of 14,290 shares of Celgene Corporation which is valued at $1,620,343 after selling 6,925 shares in Celgene Corporation , the firm said in a disclosure report filed with the SEC on Aug 15, 2016.Celgene Corporation makes up approximately 3.95% of Tanaka Capital Management Inc’s portfolio.

Other Hedge Funds, Including , Walleye Trading boosted its stake in CELG in the latest quarter, The investment management firm added 17,640 additional shares and now holds a total of 57,073 shares of Celgene Corporation which is valued at $6,471,507. Celgene Corporation makes up approx 0.49% of Walleye Trading’s portfolio.Pioneer Investment Management Inc boosted its stake in CELG in the latest quarter, The investment management firm added 400,886 additional shares and now holds a total of 4,222,301 shares of Celgene Corporation which is valued at $478,766,710. Celgene Corporation makes up approx 1.70% of Pioneer Investment Management Inc’s portfolio. Dynamic Technology Lab Private Ltd added CELG to its portfolio by purchasing 4,662 company shares during the most recent quarter which is valued at $528,624. Celgene Corporation makes up approx 0.13% of Dynamic Technology Lab Private Ltd’s portfolio.Nbt Bank N A Ny boosted its stake in CELG in the latest quarter, The investment management firm added 820 additional shares and now holds a total of 11,008 shares of Celgene Corporation which is valued at $1,271,754. Celgene Corporation makes up approx 0.22% of Nbt Bank N A Ny’s portfolio.Carnegie Capital Asset Management boosted its stake in CELG in the latest quarter, The investment management firm added 575 additional shares and now holds a total of 9,888 shares of Celgene Corporation which is valued at $1,148,392. Celgene Corporation makes up approx 0.16% of Carnegie Capital Asset Management’s portfolio.

Celgene Corporation closed down -0.37 points or -0.35% at $106.37 with 34,87,171 shares getting traded on Thursday. Post opening the session at $107.04, the shares hit an intraday low of $105.38 and an intraday high of $107.3025 and the price fluctuated in this range throughout the day.Shares ended Thursday session in Red.

On the company’s financial health, Celgene Corporation reported $1.44 EPS for the quarter, beating the analyst consensus estimate by $ 0.05 according to the earnings call on Jul 28, 2016. Analyst had a consensus of $1.39. The company had revenue of $2754.00 million for the quarter, compared to analysts expectations of $2709.02 million. The company’s revenue was up 20.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.23 EPS.

Many Wall Street Analysts have commented on Celgene Corporation. Stifel Initiated Celgene Corporation on Jul 15, 2016 to “Buy”, Price Target of the shares are set at $138.

Celgene Corporation (Celgene) together with its subsidiaries is an integrated biopharmaceutical company engaged primarily in the discovery development and commercialization of therapies for the treatment of cancer and inflammatory diseases through gene and protein regulation. The Company’s primary commercial stage products include REVLIMID (lenalidomide) ABRAXANE POMALYST/IMNOVID VIDAZA azacitidine for injection (generic version of VIDAZA) THALOMID (sold as THALOMID or Thalidomide Celgene outside the United States) OTEZLA (apremilast) and ISTODAX (romidepsin). Celgene is involved in research in a range of scientific areas designed to deliver therapies targeting areas including intracellular signaling pathways protein homeostasis and epigenetics in cancer and immune cells immunomodulation in cancer and autoimmune diseases and therapeutic application of cell therapies.

Leave a Reply

Celgene Corporation - Is it time to Sell?

Top Brokerage Firms are advising their investors on Celgene Corporation. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.